Tacrolimus in diseases other than atopic dermatitis;Tacrolimus en enfermedades diferentes a la dermatitis atópica

Actas Dermo-Sifiliograficas

Volumn 99, Issue SUPPL.2, 2008, Pages 26-35

  Alomar, A ^a   Corella, F ^a   Garcia Navarro X ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Inflammatory skin diseases; Topical tacrolimus

Indexed keywords

ANTIHISTAMINIC AGENT; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; TACROLIMUS;

ATOPIC DERMATITIS; DERMATOMYOSITIS; DRUG MECHANISM; ERYTHEMA ANNULARE CENTRIFUGUM; HUMAN; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; LICHEN STRIATUS; LICHENOID ERUPTION; LUPUS ERYTHEMATOSUS; MONOTHERAPY; NEURODERMATITIS; PHOTOTHERAPY; PSORIASIS; PYODERMA GANGRENOSUM; REVIEW; SEBORRHEIC DERMATITIS; VITILIGO;

EID: 39049115487     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(08)76208-2     Document Type: Article

References (64)

1. Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis. 2003;49:185-8.
2. Freeman AK, Serle J, Van Veldhuisen P, Lind L, Clarke J, Singer G, et al. Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis. 2004;73:267-71.
3. Thelmo MC, Lang W, Brooke E, Osborne BE, McCarty MA, Jorizzo JL, et al. An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J Dermatolog Treat. 2003;14:135.
4. Schnopp C, Remling R, Mohrenschlager M, Weigl L, Ring J, Abeck D. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol. 2002;46:73-7.
5. Shipley DR, Kennedy CT. Juvenile plantar dermatosis responding to topical tacrolimus ointment. Clin Exp Dermatol. 2006;31:453-4.
6. Wollina U. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. Am J Clin Dermatol. 2007;8:157-73.
7. Braza TJ, DiCarlo JB, Soon SL, McCall CO. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Br J Dermatol. 2003;148:1242-4.
8. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol. 2003;49:145-7.
9. Aschoff R, Wozel G. Topical tacrolimus for the treatment of lichen simplex chronicus. J Dermatolog Treat. 2007;18:115-7.
10. Fujimoto N, Tajima S, Ishibashi A. Facial lichen striatus: successful treatment with tacrolimus ointment. Br J Dermatol. 2003;148:587-90.
11. Freeman AK, Linowski GJ, Brady C, Lind L, Vanveldhuisen P, Singer G, et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol. 2003;48:564-8.
12. Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A; Tacrolimus Ointment Study Group. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004;51:723-30.
13. Steele JA, Choi C, Kwong PC. Topical tacrolimus in the treatment of inverse psoriasis in children. J Am Acad Dermatol. 2005;53:713-6.
14. Martín Ezquerra G, Sánchez Regana M, Herrera Acosta E, Umbert Millet P. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol. 2006;5:334-6.
15. Wilsmann-Theis D, Hagemann T, Dederer H, Wenzel J, Bieber T, Novak N. Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. Br J Dermatol. 2004;150:1194-7.
16. Kang HY, Choi YM. FK506 increases pigmentation and migration of human melanocytes. Br J Dermatol. 2006;155:1037-40.
17. Sardana K, Bhushan P, Kumar Garg V. Arch Dermatol. 2007;143:119; author reply 120.
18. Comment on: Effect of tacrolimus on vitiligo in absence of UV radiation exposure. Arch Dermatol. 2006;142:252-3.
19. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Álvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581-5.
20. Silverberg NB, Lin P, Travis L, Farley-Li J, Mancini AJ, Wagner AM, et. al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol. 2004;51:760-6.
21. Roe E, Dalmau J, García-Navarro X, Corella F, Monfort D, Busquets D, et al. A case of vulvar pyoderma gangrenosum associated with collagenous colitis. Dermatology. 2006;213:234-5.
22. Deckers-Kocken JM, Pasmans SG. Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum. Arch Dis Child. 2005;90:531.
23. Lally A, Hollowood K, Bunker CB, Turner R. Penile pyoderma gangrenosum treated with topical tacrolimus. Arch Dermatol. 2005;141:1175-6.
24. Vidal D, Alomar A. Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus. Br J Dermatol. 2004;150:387-8.
25. Reich K, Vente C, Neumann C. Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol. 1998;139:755-7.
26. Wells GL, Brown J, Manganiello WD, Chapman MS. Tacrolimus ointment 0.1% for the treatment of peristomal skin disease: 3 case reports. Cutis. 2006;78:258-60.
27. Werchniak AE, Storm CA, Plunkett RW, Beutner EH, Dinulos JG. Treatment of pyostomatitis vegetans with topical tacrolimus. J Am Acad Dermatol. 2005;52:722-3.
28. Kanekura T, Yoshii N, Terasaki K, Miyoshi H, Kanzaki T. Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol. 2003;148:353-6.
29. Heffernan MP, Nelson MM, Smith DI, Chung JH. 0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus. Arch Dermatol. 2005;141:1170-1.
30. Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D'Cruz DP. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford). 2004;43:1383-5.
31. Rubegni P, Sbano P, Risulo M, Poggiali S, Fimiani M. A case of reticular erythematous mucinosis treated with topical tacrolimus. Br J Dermatol. 2004;150:173-4.
32. Tzung TY, Wu JC. Topical calcineurin inhibitors in treating Jessner's lymphocytic infiltration of the skin: report of a case. Br J Dermatol. 2005;152:383-4.
33. Hollar CB, Jorizzo JL Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study. J Dermatolog Treat. 2004;15:35-9.
34. Lampropoulos CE, D' Cruz DP. Topical tacrolimus treatment in a patient with dermatomyositis. Ann Rheum Dis. 2005;64:1376-7.
35. Virgili A, Lauriola MM, Mantovani L, Corazza M. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. Acta Derm Venereol. 2007;87:69-72.
36. Assmann T, Becker-Wegerich P, Grewe M, Megahed M, Ruzicka T. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol. 2003;48:935-7.
37. Böhm M, Frieling U, Luger TA, Bonsmann G. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol. 2003;139(7):922-4.
38. Santos-Juanes J, Sánchez del Rio J, Galache C, Soto J. Topical tacrolimus: an effective therapy for Zoon balanitis. Arch Dermatol. 2004;140:1538-9.
39. Roe E, Dalmau J, Peramiquel L, Pérez M, López-Lozano HE, Alomar A. Plasma cell balanitis of zoon treated with topical tacrolimus 0.1%: report of three cases. J Eur Acad Dermatol Venereol. 2007;21:284-5.
40. Moreno-Arias GA, Camps-Fresneda A, Llaberia C, Palou-Almerich J. Plasma cell balanitis treated with tacrolimus 0.1%. Br J Dermatol. 2005;153:1204-6.
41. Jain S, Stephens CJ. Successful treatment of disseminated granuloma annulare with topical tacrolimus. Br J Dermatol. 2004;150:1042-3.
42. Harth W, Linse R. Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. Br J Dermatol. 2004;150:792-4.
43. Clayton TH, Harrison PV. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol. 2005;152:581-2.
44. Ludwig E, Allam JP, Bieber T, Novak N. New treatment modalities for granuloma faciale. Br J Dermatol. 2003;149:634-7.
45. Dalmau J, Roé E, Corella F, García-Navarro X, Alomar A. Erythema annulare centrifugum treated with tacrolimus ointment 0'1%: Report of two cases. 16 th Congress European Academy of Dermatology and Venereology. Vienna, 16-20 May, 2007.
46. Dobbs CR, Murphy SJ. Lichen nitidus treated with topical tacrolimus. J Drugs Dermatol. 2004;3:683-4.
47. Simon D, Boudny C, Nievergelt H, Simon HU, Braathen LR. Successful treatment of pityriasis lichenoides with topical tacrolimus. Br J Dermatol. 2004;150:1033-5.
48. Edmonds EV, Riaz SN, Francis N, Bunker CB. Nodular prurigo responding to topical tacrolimus. Br J Dermatol. 2004;150:1216-7.
49. Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant. 2004;19:1895-901.
50. Byrd JA, Davis MD, Bruce AJ, Drage LA, Rogers RS 3rd. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol. 2004;140:1508-12.
51. Byrd JA, Davis MD, Rogers RS 3rd. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. Arch Dermatol. 2004;140:715-20.
52. Heinemann C, Kaatz M, Schreiber G, Elsner P, Norgauer J. Topical tacrolimus in severe chronic graft-versus-host disease. Acta Derm Venereol. 2005;85:370-1.
53. Neuman DL, Farrar JE, Moresi JM, Vogelsang GB, Higman MA. Toxic absorption of tacrolimus in a patient with severe acute graft-versus-host disease. Bone Marrow Transplant. 2005;36:919-20.
54. Sand C, Thomsen HK. Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. Arch Dermatol. 2003;139:1401-2.
55. Ferraro V, Adamski H, Le Gall F, Chevrant-Breton J. Efficacy of topical tacrolimus in Hailey-Hailey disease. Ann Dermatol Venereol. 2006;133:475-6.
56. Laffitte E, Panizzon RG. Is topical tacrolimus really an effective therapy for Hailey-Hailey disease? Arch Dermatol. 2004;140:1282.
57. Ko MJ, Chu CY. Topical tacrolimus therapy for localized bullous pemphigoid. Br J Dermatol. 2003;149:1079-81.
58. Gunther C, Wozel G, Meurer M, Pfeiffer C. Topical tacrolimus treatment for cicatricial pemphigoid. J Am Acad Dermatol. 2004;50:325-6.
59. Gach JE, Ilchyshyn A. Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris. Clin Exp Dermatol. 2004;29:271-2.
60. Termeer CC, Technau K, Augustin M, Simon JC. Topical tacrolimus (protopic) for the treatment of a localized pemphigus foliaceus. J Eur Acad Dermatol Venereol. 2004;18:636-7.
61. Hara D, Kuroda K, Mieno H, Tajima S. Treatment of eosinophilic pustular folliculitis with tacrolimus ointment. J Am Acad Dermatol. 2004;51 Suppl:S143-5.
62. Uetsu N, Okamoto H, Fujii K, Doi R, Horio T. Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol. 2002;47:881-4.
63. Evans AV, Palmer RA, Hawk JL. Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus. Photodermatol Photoimmunol Photomed. 2004;20:59-61.
64. Schuster C, Zepter K, Kempf W, Dummer R. Successful treatment of recalcitrant chronic actinic dermatitis with tacrolimus. Dermatology. 2004;209:325-8.